Erythrocyte membrane changes associated with nutrition and aging — the role of plasmalogens☆
References (18)
- et al.
Methyl enol ethers as artefacts in capillary gas chromatographic profiles of aldehyde dimethyl acetals
J. Chromatogr.
(1985) - et al.
Plasma lipids and composition of red cells in four cases of Werner's syndrome
Arch. Gerontol. Geriatr.
(1986) - et al.
The effect of different fat supplemented diets on the erythrocyte ghosts and plasma lipid composition of geriatric subjects
Arch. Gerontol. Geriatr.
(1986) - et al.
Effects of age and cardiac glycosides on the activity of ATPase (EC 3.6.1.3.) of red cell ghost membranes
Mech. Ageing Dev.
(1974) Gas chromatographic determination of the fatty acid pattern of red cell membrane plasmalogens in healthy children
J. Chromatogr.
(1980)The role of membrane structure and functions in cellular aging: a review
Mech. Ageing Dev.
(1979)Statistische Verfahren — Datenanalyse mit Basic-Programmen
(1986)- et al.
Quantitative Bestimmung der Acetalphosphatide (Plasmalogene) in der Aorta des Menschen unter Berücksichtigung der Arteriosklerose
Hoppe-Seyler's Z. Physiol. Chem.
(1959) The free radical theory of aging
Cited by (6)
Dysfunctional plasmalogen dynamics in the plasma and platelets of patients with schizophrenia
2015, Schizophrenia ResearchCitation Excerpt :Data for these 2 plasmalogen pools suggest that alterations in plasmalogens in schizophrenia are more likely the result of alterations in lipid transport and/or in lipid metabolism/remodeling, rather than alterations in plasmalogen synthesis. Deficits in the levels of circulating or erythrocyte plasmalogens have also been demonstrated in patients with primary-open angle glaucoma (Acar et al., 2009), peroxisomal disorders (Aubourg and Wanders, 2013), metabolic syndrome (Brosche, 2001; Kaddurah-Daouk et al., 2007), renal failure (Stenvinkel et al., 1998, 2004; Brosche et al., 2002; Yamazaki et al., 2014), cardiovascular disease (Hoerrmann et al., 1991; Brosche et al., 2007; Maeba et al., 2007; Graessler et al., 2009; Nishimukai et al., 2014), sepsis (Brosche et al., 2013), Parkinsons' disease (Dragonas et al., 2009), Alzheimer's disease (Goodenowe et al., 2007; Wood et al., 2010; Oma et al., 2012; Trushina et al., 2013), and decreases with aging (Brosche et al., 1989; Maeba et al., 2007; Goodenowe et al., 2007). However, except for children with peroxisomal disorders, these reported decreases are all in more elderly patients, while plasmalogen decrements in schizophrenia also occur in young, first episode, non-medicated patients as well as older medicated patients (Kaddurah-Daouk et al., 2012).
Plasmalogen phospholipids - Facts and theses to their antioxidative qualities
1997, Archives of Gerontology and GeriatricsEffective lovastatin therapy in elderly hypercholesterolemic patients - An antioxidative impact?
1996, Archives of Gerontology and GeriatricsHuman and great ape red blood cells differ in plasmalogen levels and composition
2011, Lipids in Health and DiseaseEffect of exercise and high-fat diet on the concentration of plasmalogens in rat muscles
1998, Biology of SportThe Biosynthesis and Functions of Plasmalogens
1993, Journal of Clinical Biochemistry and Nutrition
- ☆
Presented in the program of a Symposium entitled ‘Aging at the Molecular, Cellular and Organism Level’ held on the occasion of the 10th anniversary of the Gerontological Institute of Friedrich-Alexander University of Erlangen-Nürnberg, 3rd June, 1989, Nürnberg, F.R.G.